Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.25 USD | +0.21% | +1.51% | -0.50% |
Mar. 01 | BACKGROUND/Capital Markets Day at Bayer: To split up or not? | DP |
Feb. 21 | Transcript : The Andersons, Inc., Q4 2023 Earnings Call, Feb 21, 2024 |
Financials (USD)
Sales 2024 * | 13.47B | Sales 2025 * | 13.73B | Capitalization | 1.94B |
---|---|---|---|---|---|
Net income 2024 * | 87M | Net income 2025 * | 110M | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
17.8
x | Employees | 2,259 |
Yield 2024 * |
1.33% | Yield 2025 * |
1.36% | Free-Float | 94.21% |
Latest transcript on The Andersons, Inc.
1 day | +1.45% | ||
1 week | +2.39% | ||
Current month | +3.69% | ||
1 month | +5.82% | ||
3 months | -2.13% | ||
6 months | +10.34% | ||
Current year | -0.38% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick Bowe
CEO | Chief Executive Officer | 65 | 15-11-01 |
Brian Valentine
DFI | Director of Finance/CFO | 54 | 18-07-31 |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert King
BRD | Director/Board Member | 68 | 05-07-28 |
Director/Board Member | 60 | 07-11-30 | |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 46 M€ | +4.03% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 57.25 | +0.21% | 144 157 |
24-03-27 | 57.32 | +1.45% | 122,161 |
24-03-26 | 56.5 | -0.21% | 112,563 |
24-03-25 | 56.62 | +1.07% | 100,064 |
24-03-22 | 56.02 | -0.67% | 83,664 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.38% | 1.94B | |
-6.89% | 1.78B | |
-5.44% | 1.26B | |
-2.97% | 1.07B | |
-6.98% | 1.04B | |
-13.26% | 1.02B | |
-16.07% | 1.02B | |
-1.64% | 662M | |
-3.84% | 435M | |
-66.86% | 357M |